Solvd Health is developing a colorectal neoplasia test that detects precancerous polyps with 90 percent accuracy.
The FDA granted the test Breakthrough Device designation in September 2019, and CMS announced Jan. 12, the test would receive Medicare coverage through a new pathway approved by the FDA.
The Medicare Coverage of Innovative Technology final rule is automatically providing devices with Breakthrough designation Medicare coverage once they receive market authorization.